INL Partners with Startup Braga and 2CA-Braga to Launch the Global Health Accelerator

January 31, 2025

A new initiative to foster innovation in health, biotechnology, and nanotechnology.

The International Iberian Nanotechnology Laboratory (INL), in collaboration with Startup Braga and the Clinical Academic Center of Braga (2CA-Braga), has announced the launch of the Global Health Accelerator, a programme designed to support early to mid-stage startups developing innovative solutions in health, biotechnology, and nanotechnology. This initiative aims to accelerate groundbreaking projects by providing startups with direct access to industry leaders, expert mentorship, and tailored entrepreneurship training.

A Strategic Platform for Innnovation:

The Global Health Accelerator offers participating startups the opportunity to: develop pilot projects and proof-of-concepts (POCs) in collaboration with key industry stakeholders; engage in intensive bootcamps focused on entrepreneurship, business development, and market strategy; and receive mentorship from experienced professionals in the health, biotechnology, and nanotechnology sectors.

Applications open until 28 February

Startups looking to scale their innovations and bring transformative solutions to the market are encouraged to apply before 28 February. More information and application details are available at globalhealthaccelerator.com.

The Global Health Accelerator is co-funded by the European Union’s Recovery and Resilience Plan (RRP) under the NextGenerationEU programme, reinforcing a commitment to fostering cutting-edge innovation in Europe’s health and technology sectors.